Page 2 - Blueprint Medicines Company Profile News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Blueprint medicines company profile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Blueprint Medicines Company Profile Today - Breaking & Trending Today

Blueprint Medicines Co. Forecasted to Earn FY2027 Earnings of $5.34 Per Share (NASDAQ:BPMC)

Blueprint Medicines Co. Forecasted to Earn FY2027 Earnings of $5.34 Per Share (NASDAQ:BPMC)
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

United States , Leerink Partnrs , Jeffreyw Albers , Christopherk Murray , Blueprint Medicines Corporation , Polar Capital Holdings Plc , Blueprint Medicines Co , Needham Company , Norges Bank , Blueprint Medicines Company Profile , Goldman Sachs Group , Securities Exchange Commission , Blueprint Medicines , Free Report , Blueprint Medicine , Get Free Report , Director Jeffrey , Exchange Commission , Capital Holdings Plc , Springs Capital Management , Partners Management , Medicines Corporation , Blueprint Medicines Daily ,

Blueprint Medicines (NASDAQ:BPMC) Upgraded at SVB Leerink

Blueprint Medicines (NASDAQ:BPMC) Upgraded at SVB Leerink
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United States , Piper Sandler , Christopherk Murray , Securities Exchange Commission , China Universal Asset Management Co , Blueprint Medicines Corporation , Blueprint Medicines Company Profile , American Century Companies Inc , Rafferty Asset Management , Blueprint Medicines , Free Report , Get Free Report , Exchange Commission , Asset Management , Century Companies , Universal Asset Management , Medicines Corporation , Blueprint Medicines Daily ,

Blueprint Medicines (NASDAQ:BPMC) PT Raised to $104.00

Blueprint Medicines (NASDAQ:BPMC) PT Raised to $104.00
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United States , Christopherk Murray , Piper Sandler , Stifel Nicolaus , Jeffreyw Albers , Polar Capital Holdings Plc , Blueprint Medicines Corporation , Norges Bank , Blueprint Medicines Company Profile , Needham Company , Securities Exchange Commission , Blueprint Medicines , Free Report , Moderate Buy , Get Free Report , Director Jeffrey , Exchange Commission , Capital Holdings Plc , Springs Capital Management , Partners Management , Medicines Corporation , Blueprint Medicines Daily ,

Blueprint Medicines (NASDAQ:BPMC) Given New $104.00 Price Target at Piper Sandler

Blueprint Medicines (NASDAQ:BPMC – Free Report) had its price target lifted by Piper Sandler from $78.00 to $104.00 in a research note published on Friday, Benzinga reports. Piper Sandler currently has a neutral rating on the biotechnology company’s stock. Several other research firms also recently commented on BPMC. Wedbush reiterated an outperform rating and issued […] ....

United States , Christopherk Murray , Piper Sandler , Needham Company , Securities Exchange Commission , American Century Companies Inc , Rafferty Asset Management , Blueprint Medicines Company Profile , China Universal Asset Management Co , Blueprint Medicines Corporation , Blueprint Medicines , Free Report , Moderate Buy , Get Free Report , Exchange Commission , Asset Management , Century Companies , Universal Asset Management , Medicines Corporation , Blueprint Medicines Daily ,

Blueprint Medicines Co. (NASDAQ:BPMC) CFO Sells $1,050,000.00 in Stock

Blueprint Medicines Co. (NASDAQ:BPMC – Get Free Report) CFO Michael Landsittel sold 10,000 shares of the business’s stock in a transaction that occurred on Thursday, May 2nd. The shares were sold at an average price of $105.00, for a total value of $1,050,000.00. Following the transaction, the chief financial officer now owns 47,286 shares of […] ....

United States , Michael Landsittel , Blueprint Medicines Company Profile , Polar Capital Holdings Plc , Blueprint Medicines Co , Norges Bank , Goldman Sachs Group , Needham Company , Blueprint Medicines Corporation , Blueprint Medicines , Get Free Report , Medicines Stock Down , Capital Holdings Plc , Springs Capital Management , Partners Management , Medicines Corporation , Blueprint Medicines Daily , Nasdaq Bpmc , Insider Trading , Nsider Trades ,